BASF and Transinsight agree to collaborate in exploring alternatives to animal testing

BASF SE and Transinsight GmbH, a provider of semantic search technologies for Web 2.0, have agreed to establish close cooperation in the area of semantic analyses to search for alternatives to animal testing. Together with the German Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung BfR), both companies will expand the first specialized semantic search engine for this research area called www.Go3R.org to become a global internet platform. In the future, experts from all over the world will be able to use this platform to bring together their knowledge on alternative and supplementary methods to animal testing.

For over 20 years, BASF has been committed to establishing alternative and supplementary methods. Since 2004, the company has been developing and validating alternatives to animal testing in its own alternatives laboratory with a research budget of 2 million euros per year. Even now alternative methods are employed in 25 percent of all the company's tests. "We are striving to increase this proportion. Transinsight's semantic search supports us in this endeavour. With the help of this highly promising technology, we - just like any other potential user - can browse the internet, internal sources, patents and specialized databases much more efficiently than before when searching for information on meaningful approaches to new alternative methods", explains Dr Robert Landsiedel, Head of the Short Term Toxicology Department at BASF.

Transinsight's semantic search engine also finds related terms and web pages that are relevant for the respective search term and thus provides considerably more accurate and comprehensive search results than conventional full text search engines. "Go3R will make a tremendous contribution to improving the process of searching for information on alternative methods", states Dr Michael R. Alvers, CEO of Transinsight. "To achieve this, we are transferring the Wikipedia concept – the largest internet encyclopaedia compiled by the community – to semantic networks of terms. Currently, this is the most efficient way to achieve a large knowledge base within a short period of time and thus to significantly reduce the amount of animal testing in the long term", Alvers continues. The www.Go3R.org platform is already available online. The service is free of charge.

About Transinsight
Transinsight develops knowledge-based semantic solutions in the Life Sciences. Their flagship products www.Go3R.org and www.GoPubMed.com, renowned biomedical search engines, are the first knowledge-based search systems of the next generation for the Life Sciences on the internet. In acknowledgement of the technologies developed by the company, Transinsight has repeatedly been honoured with international awards. The firm works in close collaboration with the Dresden University of Technology. Selected customers are: Unilever, BASF, BfR, StatoilHydro, Wintershall, AbCam and EMBL. For further information on Transinsight on the internet, see www.transinsight.com.

About BASF
BASF is the world's leading chemical company: The Chemical Company. Its portfolio ranges from oil and gas to chemicals, plastics, performance products, agricultural products and fine chemicals. As a reliable partner, BASF helps its customers in virtually all industries to be more successful. With its high-value products and intelligent solutions, BASF plays an important role in finding answers to global challenges, such as climate protection, energy efficiency, nutrition and mobility. BASF has more than 95,000 employees and posted sales of almost 58 billion euros in 2007. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN). Further information on BASF is available on the Internet at www.basf.com.

Most Popular Now

Johnson & Johnson Announces Submission to Worl…

Johnson & Johnson (NYSE: JNJ) (the Company) announced that Janssen-Cilag International N.V. has submitted for Emergency Use Listing (EUL) to the World Health Organization...

Anticancer drug may improve outcome for severe COV…

Treating severe COVID-19 patients with the anticancer drug bevacizumab may reduce mortality and speed up recovery, according to a small clinical study in Italy and China ...

Pfizer and BioNTech commence global clinical trial…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the first participants have been dosed in a global Phase 2/3 study to further evaluate the saf...

GSK and Vir Biotechnology expand coronavirus colla…

GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) have signed a binding agreement to expand their existing collaboration to include the resear...

Sanofi to provide manufacturing support to Johnson…

Sanofi has entered into an agreement with Janssen Pharmaceutical NV and Janssen Pharmaceuticals, Inc., two of the Janssen Pharmaceutical Companies of Johnson & Johnson, u...

One dose of COVID-19 vaccine provokes strong immun…

Although clinical trial data are encouraging, real-world evidence with regard to the COVID-19 vaccine remains scarce. In particular, response to the vaccine among those p...

Could a nasal spray prevent coronavirus transmissi…

A nasal antiviral created by researchers at Columbia University Vagelos College of Physicians and Surgeons blocked transmission of SARS-CoV-2 in ferrets, suggesting the n...

European Commission purchases additional 150 milli…

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Commission purchased an...

Sanofi and GSK initiate new Phase 2 study of their…

Sanofi and GlaxoSmithKline (GSK) announced the initiation of a new Phase 2 study with 720 volunteers aged 18 and over to select the most appropriate antigen dosage for Ph...

CureVac initiates rolling submission with European…

CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), today annou...

Neandertal gene variants both increase and decreas…

Last year, researchers at Karolinska Institutet in Sweden and the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany showed that a major genetic risk ...

Pfizer and BioNTech publish data from in vitro stu…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the publication in Nature Medicine of data from in vitro studies that demonstrate that sera from in...